WILSON DOW R 4
4 · VARIAN MEDICAL SYSTEMS INC · Filed Dec 9, 2020
Insider Transaction Report
Form 4
WILSON DOW R
EVP and Pres. Oncology Sys.
Transactions
- Sale
Common Stock
2020-12-07$174.35/sh−75,015$13,079,120→ 121,445 total - Exercise/Conversion
Common Stock
2020-12-07$80.40/sh+75,015$6,031,206→ 196,460 total - Sale
Common Stock
2020-12-07$174.35/sh−82,500$14,383,974→ 121,445 total - Exercise/Conversion
Non Qualified Stock Option (Right to Buy)
2020-12-07−75,015→ 0 totalExercise: $80.40Exp: 2024-02-10→ Common Stock (75,015 underlying) - Exercise/Conversion
Non Qualified Stock Option (Right to Buy)
2020-12-07−111,830→ 0 totalExercise: $81.97Exp: 2022-02-13→ Common Stock (111,830 underlying) - Exercise/Conversion
Common Stock
2020-12-07$81.97/sh+111,830$9,166,705→ 203,945 total
Footnotes (5)
- [F1]This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan
- [F2]The 82,500 shares were sold in multiple transactions executed on the same day at prices ranging from $174.31 to $174.41. The detailed breakdown of executed sales will be furnished upon request.
- [F3]The 75,015 shares were sold in multiple transactions executed on the same day at prices ranging from $174.31 to $174.44. The detailed breakdown of executed sales will be furnished upon request.
- [F4]Stock option granted under the Varian Medical Systems, Inc. Third Amended and Restated 2005 Omnibus Stock Plan, which complies with Rule 16b-3. The option vests as follows: one third on 2/13/2016, and the remaining shares in 24 equal installments over the 24 months following the first vesting date.
- [F5]Stock option granted under the Varian Medical Systems, Inc. Fourth Amended and Restated 2005 Omnibus Stock Plan which complies with Rule 16b-3. The option vests as follows: one third on 2/10/2018, and the remaining shares in 24 equal installments over the 24 months following the first vesting date.